Connor, Clark & Lunn Investment Management Ltd. - AMAG PHARMACEUTICALS INC ownership

AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 141 filers reported holding AMAG PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 1.26 and the average weighting 0.1%.

Quarter-by-quarter ownership
Connor, Clark & Lunn Investment Management Ltd. ownership history of AMAG PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2020$1,122,000
-59.1%
119,399
-66.7%
0.01%
-63.2%
Q2 2020$2,744,000
+8.7%
358,677
-12.2%
0.02%
-17.4%
Q1 2020$2,525,000
-69.5%
408,582
-39.9%
0.02%
-59.6%
Q4 2019$8,278,000
-9.7%
680,190
-14.3%
0.06%
-9.5%
Q3 2019$9,171,000
+16.1%
794,065
+0.5%
0.06%
+23.5%
Q2 2019$7,896,000
-12.8%
790,424
+12.4%
0.05%
-15.0%
Q1 2019$9,056,000
-14.5%
703,088
+0.8%
0.06%
-16.7%
Q4 2018$10,597,000
-17.4%
697,652
+8.7%
0.07%
-1.4%
Q3 2018$12,831,000
+4.3%
641,530
+1.7%
0.07%
+5.8%
Q2 2018$12,298,000
-8.8%
630,645
-5.7%
0.07%
-15.9%
Q1 2018$13,479,000
+37.7%
668,920
-9.5%
0.08%
+43.9%
Q4 2017$9,790,000
-6.0%
738,845
+30.9%
0.06%
-8.1%
Q3 2017$10,411,000
+57.0%
564,271
+56.5%
0.06%
+40.9%
Q2 2017$6,633,000
+56.8%
360,471
+92.1%
0.04%
+57.1%
Q1 2017$4,231,000
+32.2%
187,620
+104.0%
0.03%
+27.3%
Q4 2016$3,201,000
+54.3%
91,970
+8.7%
0.02%
+57.1%
Q3 2016$2,075,000
-36.2%
84,645
-37.8%
0.01%
-41.7%
Q2 2016$3,254,000
-22.2%
136,025
-23.8%
0.02%
-25.0%
Q1 2016$4,180,000
-21.4%
178,625
+1.4%
0.03%
-27.3%
Q4 2015$5,316,000
-13.4%
176,100
+13.9%
0.04%
-12.0%
Q3 2015$6,142,000
-35.3%
154,600
+12.4%
0.05%
-41.9%
Q2 2015$9,497,000
+7.1%
137,525
-15.3%
0.09%
+14.7%
Q1 2015$8,871,000
+83.9%
162,300
+43.4%
0.08%
+92.3%
Q4 2014$4,825,000113,2000.04%
Other shareholders
AMAG PHARMACEUTICALS INC shareholders Q4 2019
NameSharesValueWeighting ↓
HUNTINGTON NATIONAL BANK 1$140.00%
View complete list of AMAG PHARMACEUTICALS INC shareholders